Transforming Clinical Trials in Cardiovascular Disease Mission Critical for Health and Economic Well-being

被引：34

作者：

Antman, Elliott M. ^{[1
]}

Harrington, Robert A. ^{[2
]}

机构：

[1] Brigham & Womens Hosp, Boston, MA 02115 USA

[2] Stanford Univ, Dept Med, Stanford, CA 94305 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2012年 / 308卷 / 17期

关键词：

DESIGN;

D O I：

10.1001/jama.2012.14841

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1743 / 1744

页数：2

共 8 条

[1] Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine [J].

Antman, Elliott ;

Weiss, Scott ;

Loscalzo, Joseph .

WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 2012, 4 (04) :367-383

[2] Full Coverage for Preventive Medications after Myocardial Infarction [J].

Choudhry, Niteesh K. ;

Avorn, Jerry ;

Glynn, Robert J. ;

Antman, Elliott M. ;

Schneeweiss, Sebastian ;

Toscano, Michele ;

Reisman, Lonny ;

Fernandes, Joaquim ;

Spettell, Claire ;

Lee, Joy L. ;

Levin, Raisa ;

Brennan, Troyen ;

Shrank, William H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (22) :2088-2097

[3] Explaining the decrease in US deaths from coronary disease, 1980-2000 [J].

Ford, Earl S. ;

Ajani, Umed A. ;

Croft, Janet B. ;

Critchley, Julia A. ;

Labarthe, Darwin R. ;

Kottke, Thomas E. ;

Giles, Wayne H. ;

Capewell, Simon .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (23) :2388-2398

[4] Prioritizing Comparative-Effectiveness Research - IOM Recommendations [J].

Iglehart, John K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (04) :325-328

[5] Optimizing Trial Design Sequential, Adaptive, and Enrichment Strategies [J].

Mehta, Cyrus ;

Gao, Ping ;

Bhatt, Deepak L. ;

Harrington, Robert A. ;

Skerjanec, Simona ;

Ware, James H. .

CIRCULATION, 2009, 119 (04) :597-U199

[6] Adaptive Clinical Trials A Partial Remedy for the Therapeutic Misconception? [J].

Meurer, William J. ;

Lewis, Roger J. ;

Berry, Donald A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (22) :2377-2378

[7]

Roger VL, 2012, CIRCULATION, V125, pE2, DOI [10.1161/CIR.0b013e31823ac046, 10.1161/CIR.0b013e3182456d46]

[8]

US Food and Drug Administration Center for Drug Evaluation and Research, 2011, CDER SCI PRIOR REV C

← 1 →